Thema
F0P408N6V4
3.679
Lenalidomide
3.679
Journal Article
3.160
Thalidomide
2.452
4Z8R6ORS6L
2.449
Research Support, Non-U.S. Gov't
1.251
Dexamethasone
1.102
7S5I7G3JQL
1.099
Antineoplastic Agents
895
Bortezomib
858
69G8BD63PP
854
Review
730
Case Reports
550
Immunologic Factors
508
Letter
410
Multicenter Study
403
Pyrazines
400
Boronic Acids
399
Research Support, N.I.H., Extramural
366
Clinical Trial, Phase II
362
Angiogenesis Inhibitors
342
lenalidomide
336
Randomized Controlled Trial
251
Rituximab
249
4F4X42SYQ6
248
Multiple myeloma
237
Antibodies, Monoclonal
218
multiple myeloma
202
pomalidomide
199
Melphalan
198
Q41OR9510P
198
D2UX06XLB5
197
Clinical Trial, Phase I
195
8N3DW7272P
193
Cyclophosphamide
193
Antibodies, Monoclonal, Humanized
165
Prednisone
164
VB0R961HZT
164
Clinical Trial, Phase III
150
carfilzomib
146
Comment
142
72X6E3J5AR
140
daratumumab
135
4Z63YK6E0E
132
Comparative Study
130
Oligopeptides
127
Azacitidine
119
M801H13NRU
117
80168379AG
115
Doxorubicin
115
mehr ...